You are here

  • Home
  • Archive
  • Volume 33, Issue Suppl 4
  • EP326/#380  Efficacy and safety of nanoparticle albumin-bound paclitaxel plus carboplatin as neoadjuvant chemotherapy for women with unresectable ovarian cancer: a single-center, open phase IB/II clinical trial

Article info

Article menu

Download PDFPDF

ePoster Viewing
AS11. Ovarian cancer
EP326/#380  Efficacy and safety of nanoparticle albumin-bound paclitaxel plus carboplatin as neoadjuvant chemotherapy for women with unresectable ovarian cancer: a single-center, open phase IB/II clinical trial
Free

Authors

Citation

Yin L, Jiang W, Shan B, et al
EP326/#380  Efficacy and safety of nanoparticle albumin-bound paclitaxel plus carboplatin as neoadjuvant chemotherapy for women with unresectable ovarian cancer: a single-center, open phase IB/II clinical trial
International Journal of Gynecologic Cancer 2023;33:A211-A212.

Publication history

  • First published November 7, 2023.
Online issue publication 
November 07, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.